PhRMA Foundation/LinkedIn
May 10, 2026, 09:43
New Research Targets Immune Pathways Behind Blood Clots in APS – PhRMA Foundation
PhRMA Foundation shared a post on LinkedIn:
“In antiphospholipid syndrome (APS), harmful antibodies trigger blood clots and inflammation – sometimes even when patients are on blood thinners. PhF26 awardee Thalia Newman of the University of Michigan is targeting the immune pathways behind this process to reduce risk of blood clots in APS.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 16, 2026, 19:56Dina Ibrahem: Poor ICM vs. Poor TE
-
Oct 16, 2026, 19:47Sean Lauber: NIPT and Amniocentesis after PGT-A Reveal Few Abnormalities
-
Oct 16, 2026, 19:42Devyanshi Dixit: C-Section vs. Vaginal Birth – 2 Birth Paths, 2 Very Different Recoveries
-
Oct 16, 2026, 19:32Pawel Kordowitzki: Maternal Vitamin D Homeostasis, Pregnancy Outcomes and Offspring Health
-
Oct 16, 2026, 19:13Shizuko Takahashi: Our Study on Women’s Experiences of Assisted Reproductive Care in China Has Been Accepted by RBMO
-
Oct 16, 2026, 19:09ESHRE Announces ECRES-GESEA Reproductive Surgery Training and Certification in Slovenia
-
Oct 16, 2026, 18:20Kabita KB: What Happens if PLCZ1 Is Defective?
-
Oct 16, 2026, 18:12Partha Sarathi Das: From Reproductive Lifespan to Reproductive Healthspan
-
Oct 16, 2026, 18:05Joyce Harper: It Was a Pleasure to Give 2 Talks Celebrating World Menopause Day